Eva-Maria Collnot
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 3
- Oncology 5
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Claus‐Michael Lehr (16 shared papers)Christiane Baldes (4 shared papers)Hussain Ali (3 shared papers)Ulrich Friedrich Schaefer (4 shared papers)Michael F. Wempe (3 shared papers)Kevin J. Edgar (3 shared papers)Fransisca Leonard (2 shared papers)John A. Hyatt (2 shared papers)
- Journals
- Molecular Pharmaceutics (3 papers)Journal of Controlled Release (3 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Pharmaceutical Research (2 papers)Nanotoxicology (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Eva-Maria Collnot
18 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 124
- Pharmaceutical Science 677
- Biomaterials 488
- Molecular Medicine 83
- Oncology 317
- Pharmacology 86
Countries citing papers authored by Eva-Maria Collnot
This map shows the geographic impact of Eva-Maria Collnot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva-Maria Collnot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva-Maria Collnot more than expected).
Fields of papers citing papers by Eva-Maria Collnot
This network shows the impact of papers produced by Eva-Maria Collnot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva-Maria Collnot. The network helps show where Eva-Maria Collnot may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva-Maria Collnot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 256 | |
| 2 | 2012 | 232 | |
| 3 | 2011 | 217 | |
| 4 | 2012 | 201 | |
| 5 | 2010 | 201 | |
| 6 | 2010 | 196 | |
| 7 | 2006 | 165 | |
| 8 | 2013 | 121 | |
| 9 | 2005 | 108 | |
| 10 | 2014 | 106 | |
| 11 | 2015 | 92 | |
| 12 | 2015 | 71 | |
| 13 | 2015 | 55 | |
| 14 | 2020 | 23 | |
| 15 | 2013 | 20 | |
| 16 | 2013 | 9 | |
| 17 | 2015 | 8 | |
| 18 | 2014 | 1 |
About Eva-Maria Collnot
Eva-Maria Collnot is a scholar working on Pharmaceutical Science, Oncology, Genetics, Biomaterials and Health, Toxicology and Mutagenesis, having authored 18 papers that have together received 2.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Inflammatory Bowel Disease (5 papers), Nanoparticle-Based Drug Delivery (3 papers), Microscopic Colitis (3 papers), Advanced Drug Delivery Systems (3 papers), Lipid Membrane Structure and Behavior (2 papers), Nanoparticles: synthesis and applications (2 papers) and Protein Interaction Studies and Fluorescence Analysis (2 papers). The work is most often cited by research in Pharmaceutical Science (677 citations), Biomaterials (488 citations), Molecular Medicine (83 citations), Oncology (317 citations) and Pharmacology (86 citations). Eva-Maria Collnot has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Claus‐Michael Lehr, Christiane Baldes, Hussain Ali, Ulrich Friedrich Schaefer, Michael F. Wempe, Kevin J. Edgar, Fransisca Leonard, John A. Hyatt, Michael Linn and Katja Hempel. Their work appears in journals such as Molecular Pharmaceutics, Journal of Controlled Release, European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutical Research and Nanotoxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.